PharmaLundensis AB
PHAL | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0003359710 (+5 more)
- LEI:
- 54930082I88D5N3GQ506
- Country:
- Sweden
- Address:
- Scheelevägen 22, 223 63 Lund
- Website:
- https://pharmalundensis.se/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
PharmaLundensis is a research company. Main focus is on the treatment of severe pulmonary diseases. The three diseases the company is specialised in include chronic obstructive pulmonary disease (COPD), chronic bronchitis, and influenza-induced lung failure. In addition, development is made on system that eliminates the release of pharmaceutical pollution. PharmaLundensis is based in Lund.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-11 | Tord Staffan Håkan Skogvall | Other | Buy | 2,337 | 1,986.45 SEK |
| 2025-01-17 | SkåneÖrnen AB | Other | Buy | 121,700 | 96,143.00 SEK |
| 2025-01-17 | Tord Staffan Håkan Skogvall | Other | Buy | 10,958 | 7,999.34 SEK |
| 2024-10-14 | SkåneÖrnen AB | Other | Buy | 49,370 | 19,748.00 SEK |
| 2024-10-09 | Tord Staffan Håkan Skogvall | Other | Buy | 27,936 | 10,336.32 SEK |
| 2024-09-26 | SkåneÖrnen AB | Other | Buy | 63,000 | 29,610.00 SEK |
| 2024-09-20 | Bo Wennergren | Other | Buy | 60,000 | 27,600.00 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
BSF ENTERPRISE PLC | United Kingdom | BSFA | |
|
Can-Fite BioPharma Ltd. | Israel | CANF | |
|
Cantargia | Sweden | CANTA | |
|
Captor Therapeutics S.A. | Poland | CTX | |
|
Carbiotix AB | Sweden | CRBX | |
|
Cellectis | France | ALCLS | |
|
CELLULAR GOODS PLC | United Kingdom | CBX | |
|
Celyad Oncology SA | Belgium | CYAD | |
|
Cereno Scientific AB | Sweden | CRNO | |
|
Cessatech A/S | Denmark | CESSA |